BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21664909)

  • 1. Relationship between Cytokines and Metabolic Syndrome Components: Role of Pancreatic-Derived Factor, Interleukin-37, and Tumor Necrosis Factor-α in Metabolic Syndrome Patients.
    Abdel-Moneim A; Mahmoud R; Allam G; Mahmoud B
    Indian J Clin Biochem; 2024 Jan; 39(1):37-46. PubMed ID: 38223016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of feedback regulation between FAM3B and androgen receptor driving prostate cancer progression.
    Ma T; Jin L; Bai S; Liu Z; Wang S; Shen B; Cho Y; Cao S; Sun MJS; Fazli L; Zhang D; Wedderburn C; Zhang DY; Mugon G; Ungerleider N; Baddoo M; Zhang K; Schiavone LH; Burkhardt BR; Fan J; You Z; Flemington EK; Dong X; Dong Y
    J Natl Cancer Inst; 2024 Mar; 116(3):421-433. PubMed ID: 37847647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAM3 family genes are associated with prognostic value of human cancer: a pan-cancer analysis.
    Dong QT; Ma DD; Gong Q; Lin ZY; Li ZH; Ye JX; Qin CH; Jin WD; Zhang JX; Zhang ZY
    Sci Rep; 2023 Sep; 13(1):15144. PubMed ID: 37704682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying potential therapeutic targets of Tang-Yi-Ping for the treatment of impaired glucose tolerance: a tandem mass tag-labeled quantitative proteomic analysis.
    Li J; Bu S; Zhou H; Bi S; Xu Y
    Ann Transl Med; 2021 Oct; 9(20):1532. PubMed ID: 34790738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytokine FAM3B/PANDER is an FGFR ligand that promotes posterior development in
    Zhang F; Zhu X; Wang P; He Q; Huang H; Zheng T; Li Y; Jia H; Xu L; Zhao H; Colozza G; Tao Q; De Robertis EM; Ding Y
    Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33975953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating PANDER concentration is associated with increased HbA1c and fasting blood glucose in Type 2 diabetic subjects.
    MarElia CB; Kuehl MN; Shemwell TA; Alman AC; Burkhardt BR
    J Clin Transl Endocrinol; 2018 Mar; 11():26-30. PubMed ID: 29686968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-X
    Maciel-Silva P; Caldeira I; de Assis Santos I; Carreira ACO; Siqueira FR; Antonioli E; Goldberg AC; Belizário JE; Garay-Malpartida HM
    BMC Cancer; 2018 Jan; 18(1):90. PubMed ID: 29357840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of circulating member B of the family with sequence similarity 3 on the risk of developing metabolic syndrome and its components: A 5-year prospective study.
    Wang H; Yu F; Zhang Z; Hou Y; Teng W; Shan Z; Lai Y
    J Diabetes Investig; 2018 Jul; 9(4):782-788. PubMed ID: 29178453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAM3B mediates high glucose-induced vascular smooth muscle cell proliferation and migration via inhibition of miR-322-5p.
    Zhang W; Chen S; Zhang Z; Wang C; Liu C
    Sci Rep; 2017 May; 7(1):2298. PubMed ID: 28536423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
    Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
    Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomic profiling reveals hepatic lipogenesis and liver X receptor activation in the PANDER transgenic model.
    Athanason MG; Ratliff WA; Chaput D; MarElia CB; Kuehl MN; Stevens SM; Burkhardt BR
    Mol Cell Endocrinol; 2016 Nov; 436():41-9. PubMed ID: 27394190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated circulating level of a cytokine, pancreatic-derived factor, is associated with metabolic syndrome components in a Chinese population.
    Cao X; Yang C; Lai F; Hong Z; Lin H; Liu J; Li Y
    J Diabetes Investig; 2016 Jul; 7(4):581-6. PubMed ID: 27181109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced glucose tolerance in pancreatic-derived factor (PANDER) knockout C57BL/6 mice.
    Moak SL; Dougan GC; MarElia CB; Danse WA; Fernandez AM; Kuehl MN; Athanason MG; Burkhardt BR
    Dis Model Mech; 2014 Nov; 7(11):1307-15. PubMed ID: 25217499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PANcreatic-DERived factor: novel hormone PANDERing to glucose regulation.
    Wilson CG; Robert-Cooperman CE; Burkhardt BR
    FEBS Lett; 2011 Jul; 585(14):2137-43. PubMed ID: 21664909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic nutrient and hormonal regulation of the PANcreatic-DERived factor (PANDER) promoter.
    Ratliff WA; Athanason MG; Chechele AC; Kuehl MN; Fernandez AM; MarElia CB; Burkhardt BR
    Mol Cell Endocrinol; 2015 Sep; 413():101-12. PubMed ID: 26123584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells.
    Cao X; Gao Z; Robert CE; Greene S; Xu G; Xu W; Bell E; Campbell D; Zhu Y; Young R; Trucco M; Markmann JF; Naji A; Wolf BA
    Diabetes; 2003 Sep; 52(9):2296-303. PubMed ID: 12941769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PANDER transgenic mice display fasting hyperglycemia and hepatic insulin resistance.
    Robert-Cooperman CE; Dougan GC; Moak SL; Athanason MG; Kuehl MN; Bell-Temin H; Stevens SM; Burkhardt BR
    J Endocrinol; 2014 Mar; 220(3):219-31. PubMed ID: 24468680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of pancreatic-derived factor in type 2 diabetes: evidence from pancreatic β cells and liver.
    Wang C; Burkhardt BR; Guan Y; Yang J
    Nutr Rev; 2012 Feb; 70(2):100-6. PubMed ID: 22300596
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.